A whole new board
Published August 8, 2021
FDA’s CDER is launching a new board — the Pharmaceutical Supply Chain Governance Board — to ‘improve monitoring of the supply chain.’
FDA’s CDER is launching a new board — the Pharmaceutical Supply Chain Governance Board — to ‘improve monitoring of the supply chain.’
FOLLOW US
